中天科技(600522.SH):新增海洋系列項目訂單共計約20.42億元
格隆匯11月14日丨中天科技(600522.SH)公佈,控股子公司中天科技海纜股份有限公司和中天科技集團海洋工程有限公司陸續通過招投標和競爭性談判取得海洋系列項目的訂單。
江蘇大豐800MW海上風電項目海纜採購項目,採購內容為220kV和35kV海底光電覆合電纜及附件;山東國華HG14海上光伏1000MW項目,採購內容為66kV海陸纜及其附件設備,以上項目訂單合計金額約17.13億元。
山東能源渤中海上風電G場址工程總承包項目(標段二),採購內容為風機基礎、製作、吊裝施工及其他相關工作,項目訂單金額約3.29億元。本次新增海洋系列項目訂單共計約20.42億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.